Clinical trial
Predictor of Clinical Response to Acthar in Myositis: Phase II of Acthar Clinical Trial
NCT03414086 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictor of Clinical Response to Acthar in Myositis: Phase II of Acthar Clinical Trial
- Lead sponsor
- University of Pittsburgh
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 6, 2017
- Completion date
- July 30, 2022
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.